Qilu Pharmaceutical Reports Preliminary Results of Phase Ia Study on QLS32015
During the 66th Annual Meeting of the American Society of Hematology (ASH) held in San Diego from December 7 to 10, preliminary results from the first human trial of QLS32015, a novel...